CDKN2A and Schnyder corneal dystrophy: To further explore, we compared p16 expression in the SCD cohort to nine similarly-aged individuals who self-identified as Black/African-American from the previous AYA cancer survivor p16 study, all of whom had received prior chemotherapy [20].